You're reading a SIGNA Wire case file. Get alerts like this for free. Sign in · Learn more →
Vertex PharmaceuticalsVRTXSEC EDGARMed source confidence · 84%Jul 2, 2026, 6:30 PM UTC · 5d ago

Vertex Pharmaceuticals (VRTX) — Form 144 — Planned Share Sale

Case File

Vertex Pharmaceuticals filed a Form 144 indicating a planned share sale. The specific number of shares and sale price are not disclosed. This filing was submitted on July 2, 2026.

Sign in to follow Vertex Pharmaceuticals and get alerts like this
Key Points
  • Vertex Pharmaceuticals filed a Form 144 on July 2, 2026.
  • The filing indicates a planned share sale.
  • Details on the number of shares and price are not available.
  • This could impact the company's stock price and ownership structure.
Why This Matters

The share sale could affect existing shareholders by changing the stock's supply and potentially its price. The exact number of shares is not disclosed.

View original filing →
Sign in to follow Vertex Pharmaceuticals and get alerts like this

SIGNA Wire provides informational summaries of official government filings. Not investment advice.